Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-03-23

Clinical Trial Update: NASH: Non-invasive Diagnostic Markers and Imaging

View source ↗

Summary

An update on a Maastricht University Medical Center trial evaluating non-invasive diagnostic markers and imaging for nonalcoholic fatty liver disease and nonalc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis | Status: UNKNOWN